Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Veelbelovende ontwikkelingen in de behandeling van spierziekten
sep 2024 | Neuro-musculair